Abstract
244 - Risk Factors and Outcomes for Patients with Persistent Cytopenia Following Administration of CD19 CAR-T Cell Therapy in B Cell Lymphoma
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
